rs147259096
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_198576.4(AGRN):c.4840G>A(p.Glu1614Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,611,426 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_198576.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGRN | NM_198576.4 | c.4840G>A | p.Glu1614Lys | missense_variant | 27/36 | ENST00000379370.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGRN | ENST00000379370.7 | c.4840G>A | p.Glu1614Lys | missense_variant | 27/36 | 1 | NM_198576.4 | P1 | |
AGRN | ENST00000651234.1 | c.4525G>A | p.Glu1509Lys | missense_variant | 26/38 | ||||
AGRN | ENST00000652369.1 | c.4525G>A | p.Glu1509Lys | missense_variant | 26/35 | ||||
AGRN | ENST00000620552.4 | c.4426G>A | p.Glu1476Lys | missense_variant | 27/39 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00114 AC: 174AN: 152072Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000915 AC: 217AN: 237190Hom.: 1 AF XY: 0.000872 AC XY: 114AN XY: 130764
GnomAD4 exome AF: 0.00220 AC: 3207AN: 1459240Hom.: 6 Cov.: 72 AF XY: 0.00214 AC XY: 1551AN XY: 725926
GnomAD4 genome AF: 0.00114 AC: 174AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.000887 AC XY: 66AN XY: 74414
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 29, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | AGRN: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 28, 2023 | - - |
Congenital myasthenic syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1614 of the AGRN protein (p.Glu1614Lys). This variant is present in population databases (rs147259096, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with AGRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 474139). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at